Jude Onyia
Overview
Jude Onyia received $8M in total compensation, including $52K in salary, at Neurocrine Biosciences in 2021.
Source: SEC filing on April 7, 2022.
Related executives
We found eight more executives who work or worked at Neurocrine Biosciences.
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
Christopher O'Brien
Neurocrine Biosciences